Gamida Cell
Latest News
21/07/2008
Gamida Cell Announces License Agreement with Amgen
14/07/2008
Gamida Cell Signs Collaboration Agreement with BDS
07/11/2007
First Patient Undergoes Expanded Cord Blood Transplant

Link to StemEx
Clinical Trial

www.stemexstudy.com
Gamida Cell Ltd. is a world leader in stem cell expansion technologies and therapeutic products. The company is developing a pipeline of cell therapeutics to effectively treat debilitating and often fatal illnesses such as cancer, cardiac disease and peripheral vascular disease. Gamida Cell’s therapeutic candidates contain adult stem cells, selected from non-controversial sources such as umbilical cord blood and bone marrow, and which are enriched in culture using the company’s proprietary technologies. The company is dedicated to making a significant difference in the clinical practice of modern medicine by first creating, then tapping the regeneration power of an ample body of therapeutic stem cells.